HealthBioAI Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$500K
- Investors
-
3
HealthBioAI General Information
Description
Developer of molecular diagnostics designed for the detection and monitoring of life-threatening viral diseases. The company's diagnostics offer high throughput cellular investigation which focuses on critical life-threatening diseases such as HIV, AIDs, HPV and cervical cancer, enabling physicians to have access to single-cell testing of proteomic and genomic biomarkers in a hassle-free way.
Contact Information
Website
www.healthbioai.comCorporate Office
- 30920 Huntwood Avenue
- Hayward, CA 94544
- United States
Corporate Office
- 30920 Huntwood Avenue
- Hayward, CA 94544
- United States
HealthBioAI Timeline
HealthBioAI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 23-Jul-2024 | $500K | Completed | Generating Revenue | ||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series A1) | 08-Jan-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 10-May-2012 | $6M | $9M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 15-Jun-2010 | $3M | $3M | Completed | Startup |
HealthBioAI Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
HealthBioAI Comparisons
Industry
Financing
Details
HealthBioAI Competitors (38)
One of HealthBioAI’s 38 competitors is Hain Lifescience, a Corporate Backed or Acquired company based in Nehren, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
| Response Genetics | Corporate Backed or Acquired | Los Angeles, CA | ||||
| AusDiagnostics | Private Equity-Backed | Mascot, Australia | ||||
| Genomic Expression | Venture Capital-Backed | Beverly, MA | ||||
| Foundation Medicine | Formerly VC-backed | Cambridge, MA |
HealthBioAI Patents
HealthBioAI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4469160-A1 | Methods of treating a subject for long-haul covid-19, and compositions for use in the same | Pending | 28-Jan-2022 | ||
| US-20220317134-A1 | Methods of assigning a covid pathological type and compositions for practicing the same, and methods of treating a subject for chronic covid-19 | Pending | 21-Dec-2020 | ||
| US-20210373034-A1 | Methods of assigning a covid pathological type and compositions for practicing the same, and methods of treating a subject for chronic covid-19 | Active | 21-Dec-2020 | ||
| US-11402391-B2 | Methods of treating a long-hauler subject for chronic covid-19 by administering a ccr5 or ccl5 antagonist | Active | 21-Dec-2020 | ||
| AU-2021409658-A1 | Methods of assigning a covid pathological type and compositions for practicing the same, and methods of treating a subject for chronic covid-19 | Pending | 21-Dec-2020 | G01N33/6893 |
HealthBioAI Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
HealthBioAI Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boomerang Catapult | Venture Capital | Minority | ||
| Stony Lonesome Group | Venture Capital | Minority | ||
| BioReference Health | Corporation | Minority |
HealthBioAI FAQs
-
When was HealthBioAI founded?
HealthBioAI was founded in 2009.
-
Where is HealthBioAI headquartered?
HealthBioAI is headquartered in Hayward, CA.
-
What is the size of HealthBioAI?
HealthBioAI has 22 total employees.
-
What industry is HealthBioAI in?
HealthBioAI’s primary industry is Diagnostic Equipment.
-
Is HealthBioAI a private or public company?
HealthBioAI is a Private company.
-
What is HealthBioAI’s current revenue?
The current revenue for HealthBioAI is .
-
How much funding has HealthBioAI raised over time?
HealthBioAI has raised $20M.
-
Who are HealthBioAI’s investors?
Boomerang Catapult, Stony Lonesome Group, and BioReference Health have invested in HealthBioAI.
-
Who are HealthBioAI’s competitors?
Hain Lifescience, Response Genetics, AusDiagnostics, Genomic Expression, and Foundation Medicine are some of the 38 competitors of HealthBioAI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
